Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab. [electronic resource] by
- Hilario, A
- Sepulveda, J M
- Hernandez-Lain, A
- Salvador, E
- Koren, L
- Manneh, R
- Ruano, Y
- Perez-Nuñez, A
- Lagares, A
- Ramos, A
Producer: 20170214
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 19
Availability: No items available.
|
|
|
6.
|
|
|
|
7.
|
The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. [electronic resource] by
- Hilario, A
- Ramos, A
- Perez-Nuñez, A
- Salvador, E
- Millan, J M
- Lagares, A
- Sepulveda, J M
- Gonzalez-Leon, P
- Hernandez-Lain, A
- Ricoy, J R
Producer: 20120920
In:
AJNR. American journal of neuroradiology vol. 33
Availability: No items available.
|
|
|
8.
|
Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. [electronic resource] by
- Vera, R
- Otero, M J
- Ayala de la Peña, F
- González-Pérez, C
- Peñuelas, Á
- Sepúlveda, J M
- Quer, N
- Doménech-Climent, N
- Virizuela, J A
- Beorlegui, P
- Gorgas, M Q
Producer: 20190724
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 21
Availability: No items available.
|
|
|
9.
|
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain. [electronic resource] by
- Balañá, C
- Vaz, M A
- Lopez, D
- de la Peñas, R
- García-Bueno, J M
- Molina-Garrido, M J
- Sepúlveda, J M
- Cano, J M
- Bugés, C
- Sanz, S M
- Arranz, J L
- Perez-Segura, P
- Rodriguez, A
- Martin, J M
- Benavides, M
- Gil, M
Producer: 20141009
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 16
Availability: No items available.
|
|
|
10.
|
Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma. [electronic resource] by
- Moreno, V
- Sepulveda, J M
- Vieito, M
- Hernández-Guerrero, T
- Doger, B
- Saavedra, O
- Ferrero, O
- Sarmiento, R
- Arias, M
- De Alvaro, J
- Di Martino, J
- Zuraek, M
- Sanchez-Pérez, T
- Aronchik, I
- Filvaroff, E H
- Lamba, M
- Hanna, B
- Nikolova, Z
- Braña, I
Producer: 20210118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
|
11.
|
Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups. [electronic resource] by
- Pérez-Beteta, J
- Molina-García, D
- Villena, M
- Rodríguez, M J
- Velásquez, C
- Martino, J
- Meléndez-Asensio, B
- Rodríguez de Lope, Á
- Morcillo, R
- Sepúlveda, J M
- Hernández-Laín, A
- Ramos, A
- Barcia, J A
- Lara, P C
- Albillo, D
- Revert, A
- Arana, E
- Pérez-García, V M
Producer: 20200316
In:
AJNR. American journal of neuroradiology vol. 40
Availability: No items available.
|